Personnel Information

写真a

KITAGAWA Masanobu


Job title

Vice President

Laboratory Phone number

+81-3-5803-5173

Research Areas, Keywords

host, retrovirus, apoptosis, myelodysplastic syndromes

Graduating School 【 display / non-display

  • Tokyo Medical and Dental University, Faculty of Medicine, 1981, Graduated

Graduate School 【 display / non-display

  • Tokyo Medical and Dental University, Graduate School, Division of Medicine, Doctor's Course, 1985, Completed

Degree 【 display / non-display

  • MD, PhD, Tokyo Medical and Dental University

Campus Career 【 display / non-display

  • 2005.09
    -
    2022.03
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Advanced Therapeutic Sciences, Comprehensive Pathology, Professor
  • 2017.08
    -
    Now
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Central Clinical Facilities, Pathology, Director
  • 1997.03
    -
    2002.03
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Associate Professor
  • 2002.04
    -
    2005.08
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Advanced Therapeutic Sciences, Comprehensive Pathology, Associate Professor
  • 2022.04
    -
    2022.05
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Division of Advanced Therapeutic Sciences, Department of Comprehensive Pathology, Visiting Lecturer
  • 2022.06
    -
    2023.03
    Tokyo Medical and Dental University, Board Member, Vice President
  • 2023.04
     
     
    Tokyo Medical and Dental University, Board Member, Vice President
  • 2023.05
    -
    Now
    Tokyo Medical and Dental University, Board Member, Vice President

▼display all

Research Areas 【 display / non-display

  • Experimental pathology

  • Human pathology

Qualification Acquired 【 display / non-display

  • Doctor

 

Published Papers & Misc 【 display / non-display

  1. Yamamoto K, Abe S, Honda A, Hashimoto J, Aizawa Y, Ishibashi S, Takemura T, Hanagata N, Yamamoto M, Miura O, Kurata M, Kitagawa M.. Fatty acid beta oxidation enzyme HADHA is a novel potential therapeutic target in malignant lymphoma. Lab Invest. . 2020.03; ( DOI )

  2. Wang T, Matsuda Y, Nonaka K, Kakizaki M, Ishiwata T, Kanazawa N, Uegaki S, Muramatsu M, Sawabe M, Mori S, Kitagawa M, Arai T. . Clinicopathological characteristics of gastric cancer with carbohydrate antigen 19-9 expression occurring in elderly individuals: an autopsy study. Pathology International . 2020.02; ( DOI )

  3. Kitagawa M, Kurata M, Onishi I, Yamamoto K.. Bone marrow niches in myeloid neoplasms. Pathology International . 2020.02; ( DOI )

  4. Fukuhara N, Iwata T, Yoshimoto K, Kitagawa M, Fukuhara H, Tatsushima K, N, Iwata T, Yoshimoto K, Kitagawa M, Fukuhara H, Tatsushima K, Yamaguchi-Okada M, Takeshita A, Ito J, Takeuchi Y, Tamada S, Nishioka H, Inoshita N. . Immunohistochemistry or Molecular Analysis: Which method is better for subtyping craniopharyngioma? Endocrine Pathology . 2020;

  5. Umemori , Kurata, Yamamoto A, Yamamoto K, Ishibashi S, Ikeda M, Tashiro K, Kimura T, Sato S, Takahashi H, Kitagawa M, . The expression of MYC is strongly dependent on the circular PVT1 expression in pure Gleason pattern 4 of prostatic cancer.. Medical Molecular Morphology . 2020; ( DOI )

  6. Yanai M, Kurata M, Muto Y, Iha H, Kanao T, Ishibashi S, Ikeda M, Kitagawa M, Yamamoto K.. Clinicopathological and molecular analysis of SIRT7 in hepatocellular carcinoma. Pathology. 2020;

  7. Yamamoto A, Kurata M, Onishi I, Sugita K, Matsumura M, Ishibashi S, Ikeda M, Yamamoto K, Kitagawa M. . CRISPR screening idetidfies M1AP as a new MYC regulator with a promotor-reporter system. PeerJ. 2020; ( DOI )

  8. Takeda T, Uchihara T, Endo T, Kitagawa M, Hirokawa K, Kobayashi T, Toru S. . Numerous ballooned neurons in a 94-year-old man with dementia with Lewy bodies. J Neurol Sci . 2020; ( DOI )

  9. Matsuda M, Ninomiya H, Wakejima R, Inamura K, Okumura S, Mun M, Kitagawa M, Ishikawa Y. . Calretinin-expressing lung adenocarcinoma: distinct characteristics of advanced stages, smoker-type features, and rare expression of other mesothelial markers are useful to differentiate epithelioid mesothelioma. Pathology Res Practice. 2020;

  10. Toru S, Ishida S, Uchihara T, Hirokawa K, Kitagawa M, Ishikawa K.. Comorbid argyrophilic grain disease in an 87-year-old male patient of spinocerebellar ataxia type 31 with dementia: a case report. BMC Neurology. 2020; ( DOI )

  11. Yamaguchi N, Tomaru U Kiuchi T, Ishizu A, Deguchi T, Otsuka N, Tanaka S, Marukawa K, Matsuno Y, Kitagawa M, Kasahara M. . Expression of cathepsins B, D, and K in thymic epithelial tumors. J Clin Pathol . 2020;

  12. Tsugeno Y, Nakano K, Nakajima T, Namikawa K, Takamatsu M, Yamamoto N, Fujisaki J, Nunobe S, Kitagawa M, Takeuchi K, Kawachi H.. Histopathologic analysis of signet-ring cell carcinoma in situ in patients with hereditary diffuse gastric cancer. Am J Surg Pathol . 2020;

  13. Shintaku H, Yamaguchi M, Toru S, Kitagawa M, Hirokawa K, Yokota T, Uchihara T. . Three-dimensional surface models of autopsied human brains constructed from multiple photographs by photogrammetry. PLoS One.. 2019.07; ( DOI )

  14. Muto M, Inamura K, Ninomiya H, Okumura S, Kitagawa M, Ishikawa Y.. Pulmonary adenocarcinoma with mucin production and possible subtyping based on driver mutations and transcription factors. J Med Dent Sci. 2019.01;

  15. Mitsumura T, Ito Y, Chiba T, Matsushima T, Kurimoto R, Tanaka Y, Kato T, Uchida K, Ito T, Yamamoto K, Eishi Y, Kitagawa M, Miyazaki Y, Inase N, Asahara H.. Ablation of miR-146b in mice causes hematopoietic malignancy. Blood Adv. 2018.12;

  16. Gulinisha Aihemaiti, Morito Kurata, Daichi Nogawa, Akiko Yamamoto, Tatsunori Mineo, Iichiroh Onishi, Yuko Kinowaki, Xiao-Hai Jin, Anna Tatsuzawa, Naoyuki Miyasaka, Masanobu Kitagawa, Kouhei Yamamoto. Subcellular localization of MCM2 correlates with the prognosis of ovarian clear cell carcinoma. Oncotarget. 2018.06; 9 (46): 28213-28225. ( PubMed, DOI )

  17. Morito Kurata, Kouhei Yamamoto, Branden S Moriarity, Masanobu Kitagawa, David A Largaespada. CRISPR/Cas9 library screening for drug target discovery. J. Hum. Genet.. 2018.02; 63 (2): 179-186. ( PubMed, DOI )

  18. Yuko Kinowaki, Morito Kurata, Sachiko Ishibashi, Masumi Ikeda, Anna Tatsuzawa, Masahide Yamamoto, Osamu Miura, Masanobu Kitagawa, Kouhei Yamamoto. Glutathione peroxidase 4 overexpression inhibits ROS-induced cell death in diffuse large B-cell lymphoma. Lab. Invest.. 2018.02; ( PubMed, DOI )

  19. Hiroki Yamada, Takahiro Takeda, Toshiki Uchihara, Shizuko Sato, Susumu Kirimura, Yuka Hirota, Makoto Kodama, Masanobu Kitagawa, Katsuiku Hirokawa, Takanori Yokota, Shuta Toru. Macroscopic Localized Subicular Thinning as a Potential Indicator of Amyotrophic Lateral Sclerosis. Eur. Neurol.. 2018; 79 (3-4): 200-205. ( PubMed, DOI )

  20. Yae Ohata, Anna Tatsuzawa, Yoshio Ohyama, Ayako Ichikawa, Yumi Mochizuki, Sachiko Ishibashi, Yuri Itakura, Urara Sakurai, Kei Sakamoto, Tohru Ikeda, Masanobu Kitagawa, Kouhei Yamamoto. A distinctive subgroup of oral EBV+ B-cell neoplasm with polymorphous features is potentially identical to EBV+ mucocutaneous ulcer. Hum. Pathol.. 2017.10; 69 129-139. ( PubMed, DOI )

  21. Naoko Tsuyama, Seiji Sakata, Satoko Baba, Yuko Mishima, Noriko Nishimura, Kyoko Ueda, Masahiro Yokoyama, Yasuhito Terui, Kiyohiko Hatake, Masanobu Kitagawa, Naoki Ishizuka, Naoto Tomita, Kengo Takeuchi. BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation. Blood. 2017.05; 130 (4): 489-500. ( PubMed, DOI )

  22. Keiichi Kinowaki, Yurie Soejima, Arisa Kumagai, Fukuo Kondo, Keiji Sano, Takeshi Fujii, Masanobu Kitagawa, Toshio Fukusato. Clinical and pathological significance of myeloid differentiation factor 88 expression in human hepatocellular carcinoma tissues. Pathol. Int.. 2017.05; 67 (5): 256-263. ( PubMed )

  23. Naoki Kasahata, Tomohide Sato, Iichiroh Onishi, Masanobu Kitagawa, Toshiki Uchihara, Katsuiku Hirokawa. Three-Repeat Tau with Grain-Like Structures and Distribution in an 83-Year-Old Man. J. Alzheimers Dis.. 2017.03; 58 (3): 681-685. ( PubMed, DOI )

  24. Miyamoto K, Kurata M, Nagiri T, Yamamoto K, Onishi I, Kirimura S, Kitagawa M.. Differential expression of ACINUS variants in the bone marrow of myelodysplastic syndromes. Int J Clin Exp Pathol. 2017.01; (10): 4330-4338.

  25. Atsushi Kihara, Kimio Wakana, Toshiro Kubota, Masanobu Kitagawa. SLUG expression is an indicator of tumour recurrence in high-grade endometrial carcinomas. Histopathology. 2016.09; 69 (3): 374-382. ( PubMed, DOI )

  26. Kazuhito Suzuki, Kouhei Yamamoto, Yasuhiro Arakawa, Hisashi Yamada, Keisuke Aiba, Masanobu Kitagawa. Antimyeloma activity of bromodomain inhibitors on the human myeloma cell line U266 by downregulation of MYCL. Anticancer Drugs. 2016.09; 27 (8): 756-765. ( PubMed, DOI )

  27. Yusuke Furukawa, Kentaro Tanemura, Katsuhide Igarashi, Maky Ideta-Otsuka, Ken-Ichi Aisaki, Satoshi Kitajima, Masanobu Kitagawa, Jun Kanno. Learning and Memory Deficits in Male Adult Mice Treated with a Benzodiazepine Sleep-Inducing Drug during the Juvenile Period. Front Neurosci. 2016.07; 10 339. ( DOI )

  28. Susumu Kirimura, Morito Kurata, Yasunori Nakagawa, Iichiroh Onishi, Shiho Abe-Suzuki, Shinya Abe, Kouhei Yamamoto, Masanobu Kitagawa. Role of microRNA-29b in myelodysplastic syndromes during transformation to overt leukaemia. Pathology. 2016.04; 48 (3): 233-241. ( PubMed, DOI )

  29. Kouhei Yamamoto, Yukako Miwa, Shiho Abe-Suzuki, Shinya Abe, Susumu Kirimura, Iichiroh Onishi, Masanobu Kitagawa, Morito Kurata. Extramedullary hematopoiesis: Elucidating the function of the hematopoietic stem cell niche (Review). Mol Med Rep. 2016.01; 13 (1): 587-591. ( PubMed, DOI )

  30. Jin XH, Yamamoto K, Abe S, Onishi I, Kirimura S, Aihemaiti G, Kinowaki Y and Kitagawa M. Prognostic Impact of Cancer Stem Cell-Like Phenotypes in Pancreatic Ductal Adenocarcinoma J Clin Exp Pathol. 2016.01; 6 (5): ( DOI )

  31. Yusuke F, Kentaro T, Katsuhide I, Maky IO, Kenichi A, Satoshi K, Masanobu K, Jun K. Learning and Memory Deficits in Male Adult Mice Treated with a Benzodiazepine Sleep-Inducing Drug during the Juvenile Period Front. Neurosci.. 2016; 10 3389. ( PubMed )

  32. Shinya Abe, Kouhei Yamamoto, Morito Kurata, Shiho Abe-Suzuki, Rie Horii, Futoshi Akiyama, Masanobu Kitagawa. Targeting MCM2 function as a novel strategy for the treatment of highly malignant breast tumors. Oncotarget. 2015.10; 6 (33): 34892-34909. ( PubMed, DOI )

  33. Shuta Toru, Toshiki Uchihara, Makoto Hara, Sunao Mae, Michio Toru, Katsuiku Hirokawa, Takashi Endo, Emiko Sugawara, Masanobu Kitagawa, Takayoshi Kobayashi. An Autopsy Case of Dementia with Lewy Bodies with Vocal Cord Abductor Paralysis. Eur. Neurol.. 2015.10; 74 (3-4): 186-187. ( PubMed, DOI )

  34. Iichiroh Onishi, Yasunori Nakagawa, Toshihiko Murayama, Michihiro Hidaka, Kouhei Yamamoto, Shiho Abe-Suzuki, Shinya Abe, Morito Kurata, Masanobu Kitagawa. Expression of multidrug resistance 1 gene in association with CXCL12 in chronic myelogenous leukaemia. Pathology. 2014.12; 46 (7): 623-629. ( PubMed, DOI )

  35. Masafumi Inoue, Yoshihisa Takahashi, Takeshi Fujii, Masanobu Kitagawa, Toshio Fukusato. Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma. World J. Gastroenterol. 2014.12; 20 (46): 17541-17551. ( PubMed, DOI )

  36. Mitaka C, Hnin Si MK, Tulafu M, Yu Q, Uchida T, Abe S, Kitagawa M, Ikeda S, Eishi Y, Tomita M.. Effects of atrial natriuretic peptide on inter-organ crosstalk among the kidney, lung, and heart in a rat model of renal ischemia-reperfusion injury. Intensive Care Medicine Experimental.. 2014.11; 2 (28):

  37. Shiho Abe-Suzuki, Morito Kurata, Shinya Abe, Iichiroh Onishi, Susumu Kirimura, Manami Nashimoto, Toshihiko Murayama, Michihiro Hidaka, Masanobu Kitagawa. CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes. Lab. Invest.. 2014.11; 94 (11): 1212-1223. ( PubMed, DOI )

  38. R N Daggett, M Kurata, S Abe, I Onishi, K Miura, Y Sawada, T Tanizawa, M Kitagawa. Expression dynamics of CXCL12 and CXCR4 during the progression of mycosis fungoides. Br. J. Dermatol.. 2014.10; 171 (4): 722-731. ( PubMed, DOI )

  39. Zeyu Yang, Kentaro Nakagawa, Aradhan Sarkar, Junichi Maruyama, Hiroaki Iwasa, Yijun Bao, Mari Ishigami-Yuasa, Shigeru Ito, Hiroyuki Kagechika, Shoji Hata, Hiroshi Nishina, Shinya Abe, Masanobu Kitagawa, Yutaka Hata. Screening with a novel cell-based assay for TAZ activators identifies a compound that enhances myogenesis in C2C12 cells and facilitates muscle repair in a muscle injury model. Mol. Cell. Biol.. 2014.05; 34 (9): 1607-1621. ( PubMed, DOI )

  40. Miniwan Tulafu, Chieko Mitaka, May Khin Hnin Si, Shinya Abe, Masanobu Kitagawa, Satoshi Ikeda, Yoshinobu Eishi, Shunichi Kurata, Makoto Tomita. Atrial natriuretic peptide attenuates kidney-lung crosstalk in kidney injury. J. Surg. Res.. 2014.01; 186 (1): 217-225. ( PubMed, DOI )

  41. Shishido-Hara Y, Kitagawa M, Uchihara T.. JC viral inclusions in progressive multifocal leukoencephalopathy: Scaffolding promyelocytic leukemia nuclear bodies (PML-NBs) grow with cell cycle transition through S-to-G2-like state in the enlarging nuclei of oligodendrocytes. J Neuropathol Exp Neurol. 2014; 75 (5): 442-453.

  42. Toru S, Uchihara T, Takahashi M, Ichihara K, Endo T, Kurata M, Kitagawa M, Hirokawa K, Kobayashi T.. An autopsy verified contrast in two cases of AD with or without Lewy bodies, in terms of depletion of cardiac sympathetic nerve and [α]-synuclein deposition. European Neurol. 2010; 64 129-133.

  43. Kuninaka N, Kurata M, Yamamoto K, Suzuki S, Umeda S, Kirimura S, Arai A, Nakagawa Y, Suzuki K, Kitagawa M.. Expression of Toll-like receptor 9 in bone marrow cells of myelodysplastic syndromes is down-regulated during transformation to overt leukemia. Exp Mol Pathol. 2010; 88 293-298.

  44. Smith TJ, Yamamoto K, Kurata M, Yukimori A, Suzuki S, Umeda S, Sugawara E, Kojima Y, Sawabe M, Nakagawa Y, Suzuki K, Crawley JTB, Kitagawa M.. Differential expression of Toll-like receptors in follicular lymphoma, diffuse large B-cell lymphoma and peripheral T-cell lymphoma. Exp Mol Pathol. 2010; 89 284-290.

  45. Uchihara T, Ohashi K, Kitagawa M, Kurata M, Nakamura A, Hirokawa K, Kasuga T, Kobayashi T.. Sialidosis type I carrying V217M/G243R mutations in lysosomal sialidase. An autopsy study demonstrating terminal sialic acid in lysosomal lamellar inclusions and cerebellar dysplasia. Acta Neuropathologica. 2010; 119 135-145.

  46. Hirokawa K, Utsuyama M, Ishikawa T, Kikuchi Y, Kitagawa M, Fujii Y, Nariuchi H, Uetake H, Sugihara K.. Decline of T cell-related immune functions in cancer patients and an attempt to restore them through infusion of activated autologous T cells. Mech Ageing Dev. 2009; 130 86-91.

  47. Konstantinou K, Yamamoto K, Ishibashi F, Mizoguchi Y, Kurata M, Sawabe M, Nakagawa Y, Suzuki K, Crawley JT, Kitagawa M.. Angiogenic mediators of angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma. Br J Haematol. 2009; 144 696-704.

  48. Hasegawa M, Kurata M, Yamamoto K, Yoshida K, Aizawa S, Kitagawa M.. A novel role for acinus and MCM2 as host-specific signaling enhancers of DNA-damage-induced apoptosis in association with viral protein gp70. Leukemia Res. 2009; 33 1100-1107.

  49. Akashi T, Takemura T, Ando N, Eishi Y, Kitagawa M, Takizawa T, Koike M, Igari T, Kawachi H, Kobayashi D, Ito T, Kumagai J, Tanabe H, Ito T, Tamahashi U, Tsugata M, Chiba T, Hirooka S, Endo T, Kurata M, Yamamoto K, Warabi M, Tsunemi A, Kuroiwa T, Kayamori K, Sakamoto K, Ohtani Y, Miyazaki Y, Inase N, Yoshizawa Y.. Analysis of sixteen cases of chronic hypersensitivity pneumonitis and comparison with idiopathic pulmonary fibrosis/usual interstitial pneumonia. Am J Clin Pathol. 2009; 131 405-415.

  50. Matsumoto T, Kumagai J, Hasegawa M, Ohno K, Mizusawa H, Kitagawa M, Eishi Y.. Expression patterns of metalloproteinase in primary central nervous system lymphoma differs from those in nodal lymphoma. Neuropathology. 2008; 28 277-285.

  51. Chiba T, Shinozaki S, Nakazawa T, Kawakami A, Ai M, Kaneko E, Kitagawa M, Kondo K, Chait A, Shimokado K.. Leptin deficiency suppresses progression of atherosclerosis in apoE-deficient mice. Atherosclerosis. 2008; 196 68-75.

  52. Shiraishi J, Nakagawa Y, Kurata M, Yamamoto K, Abe Y, Toyoda Y, Suzuki K, Kitagawa M, Takemura T.. Follicular lymphoma with marked infiltration of eosinophils. Pathol Int. 2008; 58 701-705.

  53. Kurata M. Nakagawa Y, Yamamoto K, Suzuki K, Kitagawa M.. Induction of integrin β1 expression in bone marrow cells after chemotherapy correlates with the overexpression of lung resistance protein (LRP) and poor outcome in patients with multiple myeloma. Am J Hematol. 2008; 83 755-757.

  54. Horibe S, Takagi M, Unno J, Nagasawa M, Morio T, Arai A, Miura O, Ohta M, Kitagawa M, Mizutani S.. DNA damage checkpoints prevent leukemic transformation in myelodysplastic syndrome. Leukemia. 2007; 21 2195-2198.

  55. Keith T, Araki Y, Ohyagi M, Hasegawa M, Yamamoto K, Kurata M, Nakagawa Y, Suzuki K, Kitagawa M.. Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia. Br J Haematol. 2007; 137 206-215.

  56. Abe S, Hasegawa M, Yamamoto K, Kurata M, Nakagawa Y, Suzuki K, Takizawa T, Kitagawa M.. Rapid induction of IAP family proteins and Smac/DIABLO expression after proapoptotic stimulation with doxorubicin in RPMI 8226 multiple myeloma cells. Exp Mol Pathol. 2007; 83 405-412.

  57. Iizuka A, Ikarashi Y, Yoshida M, Heike Y, Takeda K, Quinn G, Wakasugi H, Kitagawa M, Takaue Y.. Interleukin (IL)-4 promotes T helper 2 biased-Natural Killer T (NKT) cell expansion, which is regulated by NKT cell-derived interferon-γ and IL-4. Immunology. 2007; 123 100-107.

  58. Wachi M, Koyama M, Utsuyama M, Bittman BB, Kitagawa M, Hirokawa K.. Recreational music-making modulates natural killer cell activity, cytokines, and mood states in corporate employees. Med Sci Monit. 2007; 13 CR57-70.

  59. Sugino Y, Misawa A, Inoue J, Kitagawa M, Hosoi H, Sugimoto T, Imoto I, Inazawa J.. Epigenetic silencing of prostagrandin E2 receptor (PTGER2) is associated with progression of neuroblastomas. Oncogene. 2007; 26 7401-7413.

  60. Kitagawa M.. The angiopoietin signaling pathway as a promising target for the treatment of acute leukemia. Haematologica. 2006; 91 1155B.

  61. Nakagawa Y, Abe S, Kurata M, Hasegawa M, Yamamoto K, Inoue M, Takemura T, Suzuki K, Kitagawa M.. IAP Family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy- induced overexpression of multidrug resistance genes. Am J Hematol. 2006; 81 824-831.

  62. Kurata M, Hasegawa M, Nakagawa Y, Abe S, Yamamoto K, Suzuki K, Kitagawa M.. Expression dynamics of drug resistance genes, multidrug resistance 1 (MDR1) and lung resistance protein (LRP) during the evolution of overt leukemia in myelodysplastic syndromes. Exp Mol Pathol. 2006; 81 249-254.

  63. Takai D, Park S-H, Takada Y, Ichinose S, Kitagawa M, Akashi M.. UV-irradiation induces oxidative damage to mitochondrial DNA primarily through hydrogen peroxide: Analysis of 8-oxodGuo by HPLC. Free Radical Res. 2006; 40 1138-1148.

  64. Hasegawa M, Yamaguchi S, Aizawa S, Ikeda H, Tatsumi K, Noda Y, Hirokawa K, Kitagawa M.. Resistance against Friend leukemia virus-induced leukemogenesis in DNA-dependent protein kinase (DNA-PK) deficient Scid mice associated with defective viral integration to the Spi-1 and Fli-1 site. Leukemia Res. 2005; 29 933-942.

  65. Abe S, Yamamoto K, Hasegawa M, Inoue M, Kurata M, Hirokawa K, Kitagawa M.. Bone marrow cells of myelodysplastic syndromes exhibit significant expression of apollon, livin and ILP-2 with reduction after transformation to overt leukemia. Leukemia Res. 2005; 29 1095-1096.

  66. Yamaguchi S, Hasegawa M, Aizawa S, Tanaka K, Yoshida K, Noda Y, Tatsumi K, Hirokawa K, Kitagawa M.. DNA-dependent protein kinase enhances DNA damage-induced apoptosis in association with Friend gp70. Leukemia Res. 2005; 29 307-316.

  67. Nakagawa Y, Hasegawa M, Kurata M, Yamamoto K, Abe S, Takemura T, Hirokawa K, Suzuki K, Kitagawa M.. Expression of IAP family proteins in adult acute mixed lineage leukemia (AMLL). Am J Hematol. 2005; 78 173-180.

▼display all

 

Social Contribution 【 display / non-display

  • Journal of Cancer Research and Clinical Oncology,Springer Nature,Journal of Cancer Research and Clinical Oncology,2017.04.01 - Now